Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

Randomized Trial ◽

Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: A long-term follow-up

Oncology Reports ◽

10.3892/or.13.1.121 ◽

2005 ◽

Cited By ~ 1

Author(s):

Yoshio Yoshida ◽

Hiromasa Sasaki ◽

Tetsuji Kurokawa ◽

Kazumi Kawahara ◽

Ken-ichi Shukunami ◽

...

Keyword(s):

Ovarian Cancer ◽

Consolidation Therapy ◽

Hyperthermic Chemotherapy ◽

Long Term Follow Up ◽

Randomized Trial of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer (SCORPION-NCT01461850)

Obstetrical & Gynecological Survey ◽

10.1097/01.ogx.0000733528.85709.c9 ◽

2021 ◽

Vol 76 (2) ◽

pp. 90-91

Author(s):

Anna Fagotti ◽

Maria Gabriella Ferrandina ◽

Giuseppe Vizzielli ◽

Tina Pasciuto ◽

Francesco Fanfani ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Randomized Trial ◽

Debulking Surgery ◽

Primary Debulking Surgery ◽

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer: A prospective randomized trial

Gynecologic Oncology ◽

10.1016/0090-8258(89)90884-6 ◽

1989 ◽

Vol 32 (1) ◽

pp. 100

Author(s):

P.E. Schwartz ◽

J.T. Chambers ◽

E.I. Kohorn ◽

S.K. Chambers ◽

H. Weitzman ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Cytotoxic Chemotherapy ◽

Prospective Randomized Trial ◽

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

Gynecologic Oncology ◽

10.1006/gyno.1999.5677 ◽

2000 ◽

Vol 76 (2) ◽

pp. 157-162 ◽

Cited By ~ 100

Author(s):

Angiolo Gadducci ◽

Flavio Carnino ◽

Silvana Chiara ◽

Isa Brunetti ◽

Lucia Tanganelli ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Intravenous Cyclophosphamide ◽

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.03.256 ◽

2019 ◽

Vol 153 (3) ◽

pp. 541-548 ◽

Cited By ~ 16

Author(s):

Martin Gore ◽

Allan Hackshaw ◽

William E. Brady ◽

Richard T. Penson ◽

Richard Zaino ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Randomized Trial ◽

Phase Iii ◽

Long Term Follow Up ◽

Gynecological Tumor

Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels

Annals of Oncology ◽

10.1093/annonc/mdn601 ◽

2009 ◽

Vol 20 (2) ◽

pp. 294-297 ◽

Cited By ~ 23

Author(s):

A. Prat ◽

M. Parera ◽

B. Adamo ◽

S. Peralta ◽

M.A. Perez-Benavente ◽

...

Keyword(s):

Ovarian Cancer ◽

Ca 125 ◽

Risk Of Recurrence ◽

Low Level ◽

Level Increase ◽

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5531 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5531-5531 ◽

Cited By ~ 1

Author(s):

Yolanda García ◽

Ana De Juan ◽

Cesar Mendiola ◽

Pilar Barretina-Ginesta ◽

Laura Vidal ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial

Cancer ◽

10.1002/1097-0142(19890315)63:6<1074::aid-cncr2820630606>3.0.co;2-0 ◽

1989 ◽

Vol 63 (6) ◽

pp. 1074-1078 ◽

Cited By ~ 49

Author(s):

Peter E. Schwartz ◽

Joseph T. Chambers ◽

Ernest I. Kohorn ◽

Setsuko K. Chambers ◽

Hervey Weitzman ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Cytotoxic Chemotherapy ◽

Prospective Randomized Trial ◽

Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.04.004 ◽

2005 ◽

Vol 98 (1) ◽

pp. 59-62 ◽

Cited By ~ 8

Author(s):

Elizabeth N. Skinner ◽

David M. Boruta ◽

Paola A. Gehrig ◽

John F. Boggess ◽

Wesley C. Fowler ◽

...

Keyword(s):

Ovarian Cancer ◽

Weekly Paclitaxel ◽

Consolidation Therapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5516 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5516-5516 ◽

Cited By ~ 21

Author(s):

Anna Fagotti ◽

Giuseppe Vizzielli ◽

Gabriella Ferrandina ◽

Francesco Fanfani ◽

Valerio Gallotta ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Randomized Trial ◽

Debulking Surgery ◽

Survival Analyses ◽

Primary Debulking Surgery ◽

Tumor Load ◽